Recent progress in the diagnosis of fungal infections in the immunocompromised host

Drug Resistance Updates

Volumn 5, Issue 1, 2002, Pages 3-10

  Erjavec, Z ^a   Verweij, P E ^b  

^a Delfzicht Ziekenhuis   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antigen detection; Diagnosis; Invasive fungal infections; PCR

Indexed keywords

FUNGAL DNA; FUNGUS ANTIGEN; GALACTOMANNAN; MANNAN; GLUCAN;

ANTIGEN DETECTION; ASPERGILLUS; CANDIDA; CLINICAL FEATURE; DNA DETERMINATION; FUNGUS CULTURE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; MOLECULAR BIOLOGY; MYCOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS; SHORT SURVEY; STANDARD; ANIMAL; FUNGUS; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY;

ANIMALS; FUNGI; GLUCANS; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROLOGY;

EID: 0036462582     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(02)00019-5     Document Type: Review

References (52)

1. Reliability of clinical research on invasive fungal infections: A systematic review of the literature
2. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
3. Diagnosis of systemic candidiasis by latex agglutination for serum antigen
4. Serum is more suitable than whole blood for diagnosis of systemic candidiasis by nested PCR
5. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR
6. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis
7. Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated candidiasis
8. Improved management of invasive aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery
9. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia
10. Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes
11. PCR and other non-culture methods for diagnosis of invasive Candida infections in allogeneic bone marrow and solid organ transplant recipients
12. Development of two real-time quantitative TaqMan PCR assays to detect circulating Aspergillus fumigatus DNA in serum
13. Detection and identification of fungal pathogens in blood by using molecular probes
14. Clinical utility of a quantitative polymerase chain reaction for diagnosis of cytomegalovirus disease in solid organ transplant patients
15. Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes
16. Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening
17. Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis
18. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients
19. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis
20. Rapid clearance of Candida albicans mannan antigens by liver and spleen in contrast to prolonged circulation of Cryptococcus neoformans antigens
21. Immunofluorescence study of Candida albicans in candidiasis, carriers and controls
22. Aspergillus galactomannan detection in the diagnosis of invasive aspergillos in cancer patients
23. Contaminations occurring in fungal PCR assays
24. Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system
25. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis
26. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: A prospective validation
27. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997
28. General primer-mediated PCR for detection of Aspergillus species
29. New method for detection of Candida albicans in human blood by polymerase chain reaction
30. Rapid, polymerase chain reaction-based identification assays for Candida species
31. Plasma (1 → 3)-α-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes
32. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species
33. Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model
34. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: Pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia
35. Molecular diagnosis and epidemiology of fungal infections
36. New enzyme immunoassays for sensitivity detection of circulating Candida albicans mannan and antimannan antibodies: Useful combined test for diagnosis of systematic candidiasis
37. Two strategies for managing invasive aspergillosis: A decision analysis
38. Trends in the epidemiology of opportunistic fungal infections: Predisposing factors and the impact of antimicrobial use practices
39. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis
40. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study
41. Serodiagnosis and monitoring of Aspergillus infections after lung transplantation
42. Panfungal PCR assay for detection of fungal infection in human blood specimens
43. Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis
44. PCR monitoring of response to liposomal amphotericin B treatment of systemic candidiasis in neutropenic mice
45. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples
46. Current trends in the detection of antigenaemia, metabolites and cell wall markers for the diagnosis and therapeutic monitoring of fungal infections
47. Detection of antigen in sera of patients with invasive aspergillosis: Intra- and interlaboratory reproducibility
48. Prospective evaluation of detection of Aspergillus DNA by PCR with bronchoalveolar lavage fluid of neutropenic patients with fever and pulmonary infiltrates
49. PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi
50. A study of Candida albicans agglutinins in human sera
51. Invasive aspergillosis: Absence of detectable antibody response
52. Enzyme immunoassays for invasive Candida infections: Reactivity of somatic antigens of Candida albicans